The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
CYCLO THERAPEUTICS INC | COM NEW | 23254X201 | 610,499 | 480,708 | SH | SOLE | 480,708 | 0 | 0 | ||
NOTABLE LABS LTD | ORD SHS | M7517R107 | 74,292 | 117,924 | SH | SOLE | 117,924 | 0 | 0 | ||
RIGETTI COMPUTING INC | COMMON STOCK | 76655K103 | 94,824 | 88,621 | SH | SOLE | 88,621 | 0 | 0 | ||
UNITY BIOTECHNOLOGY INC | COM NEW | 91381U200 | 66,382 | 49,172 | SH | SOLE | 49,172 | 0 | 0 |